4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Carcinogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashmore, JH; Lazarus, P; Luo, S; Watson, CJW | 1 |
1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Carcinogenesis
Article | Year |
---|---|
Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung.
Topics: 17-Hydroxysteroid Dehydrogenases; Carcinogenesis; Carcinogens; Cytosol; Enzyme Assays; Gene Knockdown Techniques; HEK293 Cells; Humans; Lung; Lung Neoplasms; Microsomes; Nicotiana; Nitrosamines; Oxidation-Reduction; Recombinant Proteins; RNA, Small Interfering; Smoking; Stereoisomerism | 2018 |